PLENARY LECTURE
-
Plenary Lecture 1
Lessons learned after 50+years of cancer drug development
Daniel D. Von Hoff
Translational Genomics Research Institute
USA
CV
-
Plenary Lecture 2
Rapidly expanding treatment options in lung cancer
Sanjay Popat
The Royal Marsden Hospital
UK
CV
-
Plenary Lecture 3
Cancer as a complex system:
Tumor-Stroma-Immune interactions
Linghua Wang
MD Anderson Cancer Center
USA
CV
-
Plenary Lecture 4
Hepatocellular carcinoma:
What is the big picture? and are we seeing it?
Ghassan K. Abou-Alfa
Memorial Sloan Kettering Cancer Center
USA
CV
SCIENTIFIC SYMPOSIUM
Scientific Symposium 1
Navigating current and emerging therapies for breast cancer
-
Yeon Hee Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Korea
CV
-
Paul Workman
Centre for Cancer Drug Discovery, The Institute of Cancer Research, London
UK
CV
-
Giuseppe Curigliano
European Institute of Oncology, IRCCS and Università degli Studi di Milano
Italy
CV
Scientific Symposium 2
Unlocking new immune checkpoint targets : Beyond PD-1/PD-L1 and CTLA4
-
Diwakar Davar
University of Pittsburgh
USA
CV
-
Chan Kim
CHA Bundang Medical Center
Korea
CV
-
Sarah Zaghouani
Harvard University
USA
CV
-
Yun-Gyoo Lee
Kangbuk Samsung Hospital
Korea
CV
Scientific Symposium 3
Oncology drug development: Translating biomarkers into breakthroughs
-
Seung Bum Park
Seoul National University
Korea
CV
-
Paul Workman
Centre for Cancer Drug Discovery, The Institute of Cancer Research, London
UK
CV
-
Seong-Wook Lee
Dankook University / Rznomics Inc.,
Korea
CV
Scientific Symposium 4
The forthcoming future of genitourinary cancers
-
Karim Fizazi
University of Paris-Saclay, France
France
CV
-
Se Hoon Park
Samsung Medical Center
Korea
CV
-
Pavlos Msaouel
MD Anderson Cancer Center
USA
CV
-
Ji Hyun Park
Konkuk University Medical Center
Korea
CV
Scientific Symposium 5
Emerging immunologic weapons beyond PD1, CTLA4, TIGIT, and LAG3 in lung cancer
-
Tae Min Kim
Seoul National University Hospital
Korea
CV
-
Dae Ho Lee
Asan Medical Center
Korea
CV
-
Hye Ryun Kim
Yonsei Cancer Center
Korea
CV
-
Patrick Ott
Dana-Farber Cancer Institute
USA
CV
Scientific Symposium 6
Novel therapeutic approaches for GI cancers
-
David S. Hong
The University of Texas MD Anderson Cancer Center
USA
CV
-
Choong-kun Lee
Yonsei Cancer Center
Korea
CV
-
Stephen L. Chan
Chinese University of Hong Kong
Hong Kong
CV
-
Eileen M. O'Reilly
Memorial Sloan Kettering Cancer Center (MSK)
USA
CV
Scientific Symposium 7
Artificial intelligence-driven optimization drug development process: from target discovery to phase I trial
-
Whijae Roh
Pfizer Oncology (San Diego)
USA
CV
-
Joo Sang Lee
School of Medicine, Sungkyunkwan University
Korea
CV
-
Jimmy Yen-Chu Lin
Insilico Medicine Taiwan
Taiwan
CV
-
Yi Rang Kim
CEO, Oncocross Co., Ltd.
Korea
CV
Scientific Symposium 8
Emerging ADC treatment across cancer types
-
Yong Wha Moon
CHA Bundang Medical Center
Korea
CV
-
Do-Youn Oh
Seoul National University Hospital
Korea
CV
-
Toshio Shimizu
Wakayama Medical University
Japan
CV
-
Gottfried Konecny
UCLA
USA
CV
Joint Symposium
Joint Symposium 1 (ASCO/KSMO)
Oncology innovations in cancer care - translating new discoveries into treatment for patients with cancer
-
Angela DeMichele
Abramson Cancer Center, University of Pennsylvania
USA
CV
-
Rachna Shroff
University of Arizona Cancer Center
USA
CV
-
Hyo Song Kim
Yonsei University College of Medicine
Korea
CV
-
Se-Hoon Lee
Samsung Medical Center
Korea
CV
Joint Symposium 2 (KCSG/KSMO)
Breakthrough of drug development in rare cancers
-
Eun Joo Kang
Korea University Guro Hospital
Korea
CV
-
Peter J O'Dwyer
University of Pennsylvania
USA
CV
-
Bhumsuk Keam
Seoul National University Hospital
Korea
CV
-
Konstantin Dragnev
Dartmouth Cancer Center
USA
CV
Joint Symposium 3 (ESMO/KSMO)
Emerging issues in the treatment of colon and rectal cancers
-
Minsuk Kwon
Samsung Medical Center
Korea
CV
-
Myriam Chalabi
Netherlands Cancer Institute
Netherlands
CV
-
Sun Young Kim
Asan Medical Center
Korea
CV
-
Andrés Cervantes
University of Valencia
Spain
CV
Joint Symposium 4 (KSR/KSMO)
AI application on oncology imaging
-
Hyungjin Kim
Seoul National University Hospital
Korea
CV
-
Jung Hyun Yoon
Severance Hospital, Yonsei University
Korea
CV
-
Young Kwang Chae
Northwestern University
USA
CV
Joint Symposium 5 (JSMO/KSMO)
Moving the immune checkpoint inhibitors into the partner of surgery
-
Joon Young Hur
Hanyang University Guri Hospital
Korea
CV
-
Jeong Eun Kim
Asan Medical Center
Republic of Korea
CV
-
Hidehito Horinouchi
National Cancer Center Hospital
Department of Thoracic Oncology
Japan
CV
-
Ken Kato
National Cancer Center Hospital
Japan
CV
Joint Symposium 6 (KSP/KSMO)
Application of digital pathology in precision medicine: Current and future
-
Yoon-La Choi
Samsung Medical Center
Korea
CV
-
Matthew Hanna
University of Pittsburgh Medical Center
USA
CV
-
David Joon Ho
National Cancer Center Korea
Korea
CV
-
Anil Parwani
The Ohio State University
USA
CV
Joint Symposium 7 (ASCO/KSMO)
Optimal palliative care for cancer patients
-
Lynn M. Schuchter
American Society of Clinical Oncology
USA
CV
-
Thomas W. LeBlanc
Duke University School of Medicine and the Duke Cancer Institute
USA
CV
-
Jung Yong Hong
Samsung Medical Center
Korea
CV
-
Jung Hun Kang
Gyeongsang National University
Korea
CV
Joint Symposium 8 (KSSO/KSMO)
Conversion surgery and optimal timing of systemic therapy for GI cancer
-
Junichi Shindoh
Toranomon Hospita
Japan
CV
-
David Tai
National Cancer Centre
Singapore
CV
-
Yoo Min Kim
Yonsei University College of Medicine
Korea
CV
-
So Hyun Kang
Seoul National University Bundang Hospital
Korea
CV
Joint Symposium 9 (ESMO/KSMO)
New horizon in GI cancer
-
Gerald Prager
General Hospital Vienna
Austria
CV
-
Julien Taieb
Université Paris Descartes
France
CV
-
Sae-Won Han
Seoul National University Hospital
Korea
CV
-
Hyung-Don Kim
Asan Medical Center
Korea
CV
Joint Symposium 10 (KOSRO/KSMO)
Integration of systemic therapy and radiotherapy
-
Icro Meattini
University of Florence
Italy
CV
-
Rodney Cheng-En Hsieh
Chang Gung Memorial Hospital
Taiwan
CV
-
Sun Min Lim
Yonsei Cancer Center
Korea
CV
MULTI-DISCIPLINARY CASE DISCUSSION
Multi-Disciplinary Case Discussion (KOREAN)
Optimization of treatment for BRPC/LAPC
-
Jin Won Kim
Seoul National University Bundang Hospital
Korea
CV
-
In Woong Han
Samsung Medical Center
Korea
CV
-
Eui Kyu Chie
Seoul National University Hospital
Korea
CV
EDUCATION SESSION
Education Session 1 (KOREAN)
ABCs of toxicities management for medical oncologist: Our OLD and NEW foes
-
Sung Hoon Kim
Asan Medical Center
Korea
CV
-
Su-Hyun Kim
National Cancer Center
Korea
CV
-
Hee-Jun Kim
Chung-Ang University College of Medicine
Korea
CV
-
Se Hyun Kim
Seoul National University Bundang Hospital
Korea
CV
Education Session 2 (KOREAN)
Early integration of palliative care
-
Yu Jung Kim
Seoul National University Bundang Hospital
Korea
CV
-
Shin Hye Yoo
Seoul National University Hospital
Korea
CV
-
Seockhoon Chung
Asan Medical Center
Korea
CV
-
Su-Jin Koh
Ulsan University Hospital
Korea
CV
Education Session 3 (KOREAN)
Technologies revolutionizing cancer treatment and care
-
Soo Jeong Nam
Asan Medical Center
Korea
CV
-
Seung Yoon Yang
Severance Hospital
Korea
CV
-
Junghee Yoon
Samsung Medical Center
Korea
CV
Asia Young Oncologist Forum
Speaker
-
Changhoon Yoo
Asan Medical Center, University of Ulsan College of Medicine
Korea
CV
-
Aaron Tan
National Cancer Center Singapore
Singapore
CV
-
Tawasapon Thambamroong
Phramongkutklao Hospital and College of Medicine
Thailand
CV
-
Akihiro Ohba
National Cancer Center
Japan
CV
-
Young Saing Kim
Gachon University Gil Medical Center
Korea
CV
-
Omali Pitiyarachchi
UNSW Sydney
Australia
CV
Panelist
-
Rogelio Velasco Jr.
Lung Center of the Philippines
Philippines
CV
-
Vivek Agarwala
Narayana Superspeciality Hospital & Cancer Institute
India
CV
-
-
Yueh Ni Lim
Sarawak General Hospital
Malaysia
CV
-
Hsiang-Fong Kao
National Taiwan University Cancer Center
Taiwan
CV
-
Ardhi Rahman Ahani
FKUI-RSCM
Indonesia
CV
-
Daphne Lee
Cardinal Santos Medical Center
Philippines
CV
.png)
.jpg)
